Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives
- 31 October 1975
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 11 (10), 697-707
- https://doi.org/10.1016/0014-2964(75)90043-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Experience with 4′-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosisEuropean Journal of Cancer (1965), 1974
- 4′-Demethyl-epipodophyllotoxin-β-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasmsCancer, 1974
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsEuropean Journal of Cancer (1965), 1973
- New cancer chemotherapeutic agentsCancer, 1972
- Inhibition of NADH-linked respiration with the anti-cancer agent 4′-demethyl-epipodophyllotoxin thenylidene glucoside (VM-26)European Journal of Cancer (1965), 1972
- Effect of Microsomal Activation on Interaction between Isophosphamide and DNAJournal of Pharmaceutical Sciences, 1972
- Mitosis-inhibiting natural products. 24. Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxinJournal of Medicinal Chemistry, 1971
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionEuropean Journal of Cancer (1965), 1970
- The Metaphase-Arresting Plant Alkaloids and Cancer ChemotherapyPublished by S. Karger AG ,1966
- The Similarity of the Effect of Podophyllin and Colchicine and Their Use in the Treatment of Condylomata AcuminataScience, 1946